Beneficient (NASDAQ:BENF) has a beta value of -0.69 and has seen 44.95 million shares traded in the last trading session. The company, currently valued at $3.85M, closed the last trade at $0.44 per share which meant it gained $0.08 on the day or 23.39% during that session. The BENF stock price is -1325.0% off its 52-week high price of $6.27 and 50.0% above the 52-week low of $0.22.

Beneficient (NASDAQ:BENF) trade information

Sporting 23.39% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the BENF stock price touched $0.44 or saw a rise of 28.5%. Year-to-date, Beneficient shares have moved -40.34%, while the 5-day performance has seen it change 30.76%. Over the past 30 days, the shares of Beneficient (NASDAQ:BENF) have changed 58.64%.

Beneficient (BENF) estimates and forecasts

The company’s shares have lost -56.45% over the past 6 months.

1 analysts offering their estimates for the company have set an average revenue estimate of 210k for the current quarter.

BENF Dividends

Beneficient is expected to release its next earnings report in July this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Also the top two Mutual Funds that are holding company’s shares are Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . As of Mar 31, 2025 , the former fund manager holds about 0.53% shares in the company for having 44.69 shares of worth $19849.0 while later fund manager owns 12.03 shares of worth $5342.0 as of Mar 31, 2025 , which makes it owner of about 0.14% of company’s outstanding stock.